Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism PPARγ agonists(Peroxisome proliferator-activated receptor γ agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H18F3N3O |
InChIKeyFKOGVRJHWTYNKL-UHFFFAOYSA-N |
CAS Registry2415360-75-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Triple Negative Breast Cancer | Preclinical | CN | 08 Jan 2018 |